HER-1 and HER-2 Targeting in Cancer

[Barbara2]

www.cancernetwork.com/her2/october_2005/2.html

A review of the biology and pharmacology of Her inhibitors.

[Christine MH-UK]

Thanks for that. It was really good on laying out where the science was heading for Her2, especially her2 ER+. It was frustrating, however, to see how little progress there has been in targeting her1 by itself, since the triple negatives could sure use some help.

[AlaskaAngel]

Okay, I don't understand everything I read, but thanks for giving me something worth reading to chew on.

A.A.